Pharmafile Logo

Research Partnership is on the rise

December 21, 2021 | Mark Jeffrey, Pharma, global healthcare 

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

The UK’s best performing market research agencies were revealed this week with the publication of Research Live’s Industry Report for 2021, which includes the latest Market Research Society (MRS) League Tables. Based on available 2020 financial data that was compiled and analysed in November 2021, the MRS league tables identify and rank the best-performing research agencies and businesses according to their UK-based turnover and by their year-on-year growth.

In a very challenging year globally, Research Partnership bucked the trend by achieving an impressive 21% growth against an industry average of 0.8%. Less than half of the top 100 companies reported any growth.

Research Partnership ranked 23rd in the top individual agencies with a confirmed turnover of £40.297m and remains the UK’s largest individual healthcare consulting specialist.

The company ranked 7th in the top 20 fastest-growing businesses and 12th in the top 20 fastest-growing individual agencies.

Joint Founding Director Mark Jeffery commented, “Research Partnership has achieved considerable growth in a very turbulent climate. Fortunately, we were able to pivot quickly to remote working using online methodologies and we responded effectively to increased demand from our clients. Last year, we continued our recruitment drive and increased our headcount from 216 to 250 with appointments made across the US, EU and APAC offices. We also continued to grow both our market research and market access services, and we are winning business from both new and existing clients across the pharmaceutical, medtech and biotech sectors. According to our customer survey, satisfaction with insights and recommendations remained high and we are still delivering the quality service expected of us.”

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.